Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Nov 14, 2006

RexGene and Eugene Science Collaborate on Nutraceuticals in Cholesterol Market

  • RexGene Biotech will manufacture and market several cholesterol-lowering nutraceutical products containing Eugene Science's water soluble CZ™ plant sterol ingredient, under a strategic distribution alliance between the two firms. "The Eugene Science water-soluble CZ ingredient is the ideal platform upon which RexGene will create a large and important new product line that we are confident will be met with strong demand by South Korea's 50 million consumers," points out Il Jae Jung, senior marketing manager, RexGene.

    RexGene plans to develop and launch the first CZ-based products beginning in January, 2007, followed by several other product launches throughout the first half of 2007. RexGene's forecast for CZ purchases to support a mass-market, multiproduct line of cholesterol-lowering supplements indicates that it will become one of Eugene Science's largest customers in early 2007.

    Additionally, Eugene Science retains overseas distribution rights, including in the U.S., for RexGene-manufactured CZ products.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »